1. Home
  2. News
  3. Sandu Pharmaceuticals Limited
  4. Intimation Regarding Change In Name Of Director From Dr Neeti Madan Kapre To Dr Neeti Gupta.
More Sandu Pharmaceuticals Limited news
Sandu Pharmaceuticals LimitedBSE: SANDUPHQ

Intimation Regarding Change In Name Of Director From Dr Neeti Madan Kapre To Dr Neeti Gupta.

Oct 9, 2026 at 2:10 AM EDT · Issued by Sandu Pharmaceuticals Limited via BSE India

Filed with BSE · Oct 9, 2026 at 2:10 AM EDT · 2 pages · English

On 6ix: 6ix.com/news/intimation-regarding-change-in-name-of-director-from-dr-neeti-madan-kapre-to-dr-neeti-gupta

Sandu Pharmaceuticals Limited on 6ix

Earlier from Sandu Pharmaceuticals

  • Sandu Pharmaceuticals Limited Press Release Sep 30 2026Sep 30
  • Intimation To The Holders Of Physical Securities To Furnish PAN And KYC DetailsSep 30
  • Sandu Pharmaceuticals Limited Press Release Sep 04 2026Sep 4
  • Sandu Pharmaceuticals Limited Press Release Aug 20 2026Aug 20
  • Sandu Pharmaceuticals Limited Press Release Aug 19 2026Aug 19
All Sandu Pharmaceuticals news releases↗

Follow Sandu Pharmaceuticals into a list and get an email when it puts out news.

Follow Sandu Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer